3 Monster Stocks to Hold for the Next 10 Years

The article recommends three healthcare stocks as long-term investments: Eli Lilly, benefiting from the high-growth weight loss drug market; AbbVie, successfully transitioning from Humira patent expiration with new immunology drugs; and Abbott Laboratories, offering diversification across medical devices, diagnostics, nutrition, and pharmaceuticals. These established companies are positioned for sustained growth over the next decade.

06/23/2026, 6:05 AM • The Motley Fool

Enteric Disease Testing Market Worth USD 5.86 Billion by 2035 | SNS Insider

The global Enteric Disease Testing Market is valued at USD 4.08 billion in 2025 and is projected to reach USD 5.86 billion by 2035, growing at a CAGR of 3.70%. Growth is driven by increasing foodborne and waterborne disease prevalence, rising demand for rapid pathogen detection, and expanding adoption of multiplex molecular diagnostics. North America and Europe are leading markets, with Asia-Pacific emerging as the fastest-growing region.

06/23/2026, 4:35 AM • GlobeNewswire

5 Dividend Stocks to Buy and Hold Forever

The article highlights five blue-chip dividend stocks suitable for long-term buy-and-hold investing: AbbVie, McDonald's, Johnson & Johnson, Walmart, and Becton Dickinson. These companies have demonstrated decades of consecutive dividend increases and strong financial fundamentals, with dividends well-covered by earnings and solid growth prospects ahead.

06/22/2026, 6:15 AM • The Motley Fool

Ovarian Cancer Diagnostics Market Size to Reach USD 8.08 Billion by 2035 | SNS Insider

The global ovarian cancer diagnostics market is valued at USD 4.92 billion in 2025 and is projected to reach USD 8.08 billion by 2035, growing at a CAGR of 5.06%. Growth is driven by rising ovarian cancer incidence, increasing adoption of AI-powered imaging, biomarker testing, and precision oncology diagnostics. North America leads with 41.2% market share, while imaging and hospital laboratories dominate their respective segments.

06/19/2026, 5:39 AM • GlobeNewswire

The Hormuz Reopening Trade: These 20 Large-Cap Stocks Still Haven't Caught Up To Pre-War Levels

Following President Trump's announcement of a U.S.-Iran peace deal and the reopening of the Strait of Hormuz, oil prices plunged 5.4% to $80/barrel. However, 20 large-cap stocks worth over $100 billion remain trading 15-24% below their pre-war levels from February 27, 2026. The laggards span consumer staples, healthcare, software, and mining sectors, with weakness extending beyond the war premium as these companies face ongoing margin pressures from higher energy costs.

06/15/2026, 11:29 AM • Benzinga

Over 100 Organizations Thank America’s Blood Donors on World Blood Donor Day

More than 100 prominent organizations have united to promote World Blood Donor Day on June 14, 2026, and Blood Advocacy Week (June 8-12). The initiative highlights that while blood transfusions are needed every 2 seconds in America, less than 3% of eligible Americans donate blood. The campaign theme is 'One Drop of Humanity. Give Blood. Save Lives.' emphasizing the critical need for volunteer blood donors.

06/14/2026, 8:54 AM • GlobeNewswire

Meet the Medtech Stock Wall Street Thinks Will Soar 65% Over the Next 12 Months

Boston Scientific shares have plummeted over 50% year-to-date due to repeated downward guidance revisions, particularly regarding declining Watchman procedure usage. Despite bearish market sentiment, 27 of 31 analysts maintain buy ratings with a consensus price target of $78 (65% upside), though the article cautions this recovery may be challenging without faster-than-expected growth acceleration.

06/13/2026, 12:15 AM • The Motley Fool

Abbott declares 410th consecutive quarterly dividend

Abbott Laboratories announced its 410th consecutive quarterly dividend of 63 cents per share, payable on August 17, 2026. The company has increased its dividend for 54 consecutive years and is a member of the S&P 500 Dividend Aristocrats Index.

06/12/2026, 2:29 PM • Benzinga

Can Beyond Meat's Pivot to Protein Drinks Change the Investment Thesis?

Beyond Meat has launched Beyond Immerse protein drinks to counter declining plant-based meat sales, which fell 16% in 2025. The company faces significant financial challenges with $333 million in operating losses and must compete against industry giants like PepsiCo, Coca-Cola, and Abbott Laboratories in the $35 billion protein drink market. Analysts remain skeptical about whether this pivot can turn around the struggling company, noting the limited-time nature of the product launch and lack of early financial improvements.

06/08/2026, 1:05 PM • The Motley Fool

Why Grail Could Be the Sleeper Stock Everyone's About to Notice

Grail, a leader in multi-cancer early detection (MCED) testing, could be poised for significant growth as its Galleri test shows promising clinical trial results. The company awaits FDA approval and potential insurance reimbursement, which could unlock a $50 billion market opportunity. However, the stock remains high-risk due to unprofitability and competition from larger players.

06/08/2026, 5:25 AM • The Motley Fool

A Grandma Bought PediaSure To Help Her Grandson Grow — Now, Abbott Is In Federal Court

A federal judge ruled that Abbott Laboratories must defend against a class-action lawsuit alleging it misled consumers about PediaSure Grow & Gain drinks. The judge found that Abbott's marketing, including packaging with a giraffe and ruler markings, could reasonably be interpreted as promising height growth, despite the company's claims only stating the product helps kids 'grow' without specifying the type of growth.

06/05/2026, 1:57 PM • Benzinga

Chemiluminescence Immunoassay Market Expected to Reach USD 16.39 Billion by 2031 | MarketsandMarkets™

The global chemiluminescence immunoassay (CLIA) market is projected to grow from USD 11.58 billion in 2026 to USD 16.39 billion by 2031, with a CAGR of 7.2%. Growth is driven by rising demand for high-sensitivity diagnostic testing, automated laboratory systems, increasing prevalence of chronic and infectious diseases, and technological advancements including AI-enabled automation. Asia Pacific is emerging as a high-growth region, while hospitals lead market adoption.

06/05/2026, 10:30 AM • GlobeNewswire

[Latest] Non-Invasive Blood Glucose Monitoring Devices Market Size to Hit USD 340.49 Million with a Promising CAGR of 25.60% by 2034 - Report by Zion Market Research (ZMR)

The global non-invasive blood glucose monitoring devices market is projected to grow from USD 34.86 million in 2024 to USD 340.49 million by 2034, with a CAGR of 25.60%. Growth is driven by rising diabetes prevalence, increasing demand for painless monitoring, and technological advancements in wearables and optical sensing. Spectroscopy technology and homecare segments are expected to lead the market, while North America will dominate regionally.

06/04/2026, 1:53 PM • GlobeNewswire

1 Sector Warren Buffett and Greg Abel Are Largely Ignoring -- and Why Investors Shouldn't

Warren Buffett and Greg Abel's Berkshire Hathaway portfolio is notably absent from the healthcare sector, holding only DaVita and recently exiting UnitedHealth Group. The article argues investors should consider healthcare independently, as it offers opportunities across multiple investment styles—from high-growth pharma/biotech plays like Eli Lilly to dividend-paying stalwarts like Johnson & Johnson and Abbott Laboratories that provide steady earnings and income.

06/03/2026, 12:05 PM • The Motley Fool

Protein Supplements Market to Grow at 7.7% CAGR by 2031 Fueled by Rising Sports Nutrition Demand and Health and Wellness Trends, Reports Mordor Intelligence

The global protein supplements market is projected to grow from USD 30.30 billion in 2026 to USD 43.98 billion by 2031, driven by mainstream fitness adoption, plant-based innovations, RTD products, and rapid Asia-Pacific expansion. Growth is supported by social media influence, sports sponsorships, technological advancements in protein extraction, and expanding consumer segments beyond traditional athletes.

06/03/2026, 3:39 AM • GlobeNewswire